Cite
HARVARD Citation
Desborough, M. et al. (2020). Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): protocol for a phase II double-blind randomised controlled feasibility trial. BMJ open. 10 (11), p. . [Online].